Safety and Tolerability of Donepezil With Solifenacin in Patients With Dementia of the Alzheimer's Type Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2017
At a glance
- Drugs Donepezil/solifenacin (Primary) ; Solifenacin
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Chase Pharmaceuticals
- 30 Jan 2017 Status changed from active, no longer recruiting to completed.
- 25 Jul 2016 Planned End Date changed from 1 Jul 2016 to 1 Dec 2016.
- 25 Jul 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Dec 2016.